Heart Failure Pathogenesis and Management
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425).
Deadline for manuscript submissions: closed (1 June 2017) | Viewed by 72362
Special Issue Editor
Interests: inflammation; macrophage; diabetes; cardiomyopathy; diabetic complications; lipid metabolism
Special Issue Information
Dear Colleagues,
The Journal of Cardiovascular Development and Disease is launching a Special Issue on “Heart Failure Pathogenesis and Management”. Heart failure remains a leading cause of morbidity and mortality worldwide. With the aging population, increasing prevalence of diabetes, and better therapies for acute coronary syndromes the number of patients with heart failure will continue to increase at a staggering rate. At the same time, there have been several major advancements in our understanding of heart failure pathogenesis, which have led to novel therapeutic approaches. With this Special Issue, we aim to present the most up-to-date information about heart failure development, diagnosis, and management. Insights into both heart failure with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF) will be included. In addition, exciting new developments in the molecular pathogenesis of adverse cardiac remodeling will be emphasized.
Dr. Joel D. Schilling
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Heart failure with preserved ejection fraction (HFpEF)
- cardiac macrophage
- pulmonary hypertension
- adverse cardiac remodelling
- post-MI heart failure
- cardiac metabolism
- Cardiac imaging
- Arrhythmias
- Diabetes
- exercise
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.